Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing Cancer Hospital, Beijing

Beijing Luhe Hospital, Capital Medical University, Beijing

Liaoning Cancer Hospital and Institute, Shenyang

Jilin Cancer Hospital, Changchun

Harbin Medical University Cancer Hospital, Harbin

Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai

Affiliated Zhongshan Hospital of Fudan University, Shanghai

Northern Jiangsu Peoples Hospital, Yangzhou

Anhui Provincial Hospital South Brance, Hefei

Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital, Hefei

Shandong Cancer Hospital, Jinan

Weifang Peoples Hospital, Weifang

Tianjin Medical University General Hospital, Tianjin

Zhejiang Cancer Hospital, Hangzhou

The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang

Ganzhou Peoples Hospital Ganzhou Hospital Affiliated to Nanchang University, Ganzhou

The First Affiliated Hospital of Fujian Medical University, Fuzhou

Fujian Cancer Hospital, Fuzhou

Hunan Cancer Hospital, Changsha

Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Xiangyang Central Hospital, Xiangyang

Henan Cancer Hospital, Zhengzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang

Sun Yat Sen University Cancer Center, Guangzhou

Sun Yat Sen University Cancer Center(Huangpu Campus), Guangzhou

Cancer Hospital of Shantou University Medical College, Shantou

The Tumor Hospital Affiliated to Guangxi Medical University, Nanning

West China Hospital, Sichuan University, Chengdu

Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu